Trial · NCT01854632
Outcomes11
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Percentage of Participants With Symptomatic, Laboratory-confirmed Influenza Virus Infection (Regardless of Vaccine Match) | Through 7 to 8 months post vaccination | All participants meeting per-protocol analysis criteria. | percentage of participants | NUMBER |
| SECONDARY | Safety Profile of LAIV: Immediate Reactions Occurring Within 30 Minutes of Administration of Study Vaccine. | Through 30 minutes post vaccination | |||
| SECONDARY | Safety Profile of LAIV: Solicited and Unsolicited Local and Systemic Reactions | Through 7 days post vaccination | |||
| SECONDARY | Safety Profile of LAIV: Serious Adverse Events | Through 1 month post vaccination | |||
| SECONDARY | Safety Profile of LAIV: Other Non-serious Adverse Events | Through 1 month post vaccination | |||
| SECONDARY | Safety Profile of LAIV: Protocol Defined Wheezing Illness | Through 7 to 8 months post vaccination | |||
| SECONDARY | Percentage of Participants With Symptomatic, Laboratory-confirmed Influenza Virus Infection (Vaccine-matched Strains) | Through 7 to 8 months post vaccination | |||
| SECONDARY | Percentage of Participants With Symptomatic, Laboratory-confirmed Influenza Virus Infection by Influenza Type/Subtype (Influenza A/H1N1, Influenza A/H3N2, and Influenza B) | Through 7 to 8 months post vaccination | |||
| SECONDARY | Clinical Characteristics of Influenza in the Study Population | Through 7 to 8 months post vaccination | |||
| SECONDARY | Etiologies of Influenza-like Illness in the Study Population | Through 7 to 8 months post vaccination | |||
| SECONDARY | Evaluation of Vaccine-take as Shedding of Vaccine Virus Post-vaccination, Including Viral Load and Duration of Virus Detection | Through 4 days post vaccination |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01854632/outcomes